Silverman Joshua bought PMCB

January 5, 2026 · Form 4 insider transaction

Silverman Joshua bought 30,000 shares of PharmaCyte Biotech, Inc. at $0.78 per share, a transaction worth $23.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.